Patrick Lin
Chief Business - Strategy Off · 9 filings · Latest: Jul 26, 2026
Processa Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PCSA | Patrick Lin | Chief Business - Strategy Off | Jun 30, 2026 | Purchase | $1.93 | 2,106 | $4.1K | 13,113 | |
PCSA | Patrick Lin | Chief Business - Strategy Off | Jun 15, 2026 | Purchase | $2.22 | 1,831 | $4.1K | 11,007 | |
PCSA | Patrick Lin | Chief Business - Strategy Off | May 29, 2026 | Purchase | $2.57 | 1,582 | $4.1K | 9,176 | |
PCSA | Patrick Lin | Chief Business - Strategy Off | May 15, 2026 | Purchase | $2.97 | 1,369 | $4.1K | 7,594 | |
PCSA | Patrick Lin | Chief Business - Strategy Off | Apr 30, 2026 | Purchase | $2.69 | 1,511 | $4.1K | 6,236 | |
PCSA | Patrick Lin | Chief Business - Strategy Off | Apr 15, 2026 | Purchase | $2.97 | 1,369 | $4.1K | 4,725 | |
PCSA | Patrick Lin | Chief Business - Strategy Off | Mar 31, 2026 | Purchase | $2.54 | 1,603 | $4.1K | 3,356 | |
PCSA | Patrick Lin | Chief Business - Strategy Off | Jan 1, 2026 | Option Exercise | $0.00 | 193 | — | 1,753 |